Shanghai Rendu Biotechnology Co Stock

Shanghai Rendu Biotechnology Co Forward P/E

The Forward P/E Ratio of Shanghai Rendu Biotechnology Co (688193.SS) as of Aug 5, 2026 is -265.47. In the previous year, Forward P/E Ratio was 251.10 — a change of -205.72% (lower).

Forward P/E

-265.47

YoY

-205.72%

Last updated:

Forward P/E Ratio of Shanghai Rendu Biotechnology Co is 2026 -265.47 . Forward P/E Ratio of Shanghai Rendu Biotechnology Co was 2025 251.10 . It decreases by -205.72% lower compared to the previous year.
Access this data via the Eulerpool API

Shanghai Rendu Biotechnology Co Stock analysis

What does Shanghai Rendu Biotechnology Co do? Shanghai Rendu Biotechnology Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Shanghai Rendu Biotechnology Co stock

Forward P/E Ratio of Shanghai Rendu Biotechnology Co is -265.47 in 2026.

Forward P/E Ratio of Shanghai Rendu Biotechnology Co changed from 251.10 to -265.47, representing a -205.72% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Shanghai Rendu Biotechnology Co since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Shanghai Rendu Biotechnology Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Shanghai Rendu Biotechnology Co

All Key Metrics — Shanghai Rendu Biotechnology Co